​

Heart Test Laboratories Stock (NASDAQ:HSCS)

ForecastRevenueOwnershipFinancialsChart

Previous Close

$3.31

52W Range

$2.36 - $18.50

50D Avg

$3.42

200D Avg

$4.63

Market Cap

$3.20M

Avg Vol (3M)

$35.80K

Beta

3.29

Div Yield

-

HSCS Company Profile

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15

IPO Date

Jun 16, 2022

Website

HSCS Performance

HSCS Financial Summary

Apr 24Apr 23Apr 22
Revenue$18.60M$5.15K$14.37K
Operating Income$-6.31B$-6.11M$-4.71M
Net Income$-6.61B$-490.85M$-4.58M
EBITDA$-6.31B$-6.08M$-4.68M
Basic EPS$-18.74$-61.74$-0.02
Diluted EPS$-18.74$-61.74$-0.02

Fiscal year ends in Apr 24 | Currency in USD

Peer Comparison

TickerCompany
NURONeuroMetrix, Inc.
BVSBioventus Inc.
RSLSReShape Lifesciences Inc.
BBLGBone Biologics Corporation
TNONTenon Medical, Inc.
NUWENuwellis, Inc.
TIVCTivic Health Systems, Inc.
BJDXBluejay Diagnostics, Inc.
IINNInspira Technologies Oxy B.H.N. Ltd.